Research & Innovation

Using our antibody expertise to transform how cancer is treated

As a leader in the discovery and development of antibody therapeutics, we are inspired by nature, passionate about innovation and driven by data. Our commitment to patients pushes us to use our antibody biology expertise to pursure and produce differentiated, next-generation cancer treatments.

Our research and innovation teams consist of a strong antibody discovery engine connecting our antibody platform technologies with our target and disease biology knowledge. This synergy is the lifeblood of our R&D organization, where our creations enter clinical development.

Get to know our technologies

Our Product Discovery

We are pioneering technologies to transform the future of cancer treatments

We strive to improve the lives of patients with cancer by creating and developing innovative antibody-based products. This commitment is deeply rooted in science.

With a deep knowledge of the power of the human immune system and a proven track record for inventing and engineering novel therapeutic antibodies, we aim to tackle and overcome the challenges in oncology drug development.

In our product discovery, we connect our innovative antibody platform technologies with our robust target and disease biology knowledge to create novel and differentiating products.

Our differentiated pipeline stands as proof of our ability to identify and address the areas of unmet treatment need and includes three Genmab-created* antibodies approved by the U.S. Food and Drug Administration with breakthrough designations—Daratumumab, Ofatumumab and Teprotumumab.

Out-licensed products marketed by partner

Rooted in science and driven by data, we are transforming the future of human antibody therapeutics.

Explore our technology platforms

  • Sponsorships & grants

    We regularly support a variety of medical
    grants and sponsorships

    Learn more

  • Turning insights into medicine

    See the results of innovation that is
    rooted in science

    Explore the pipeline

  • Innovate with us

    Be a part of our team and help transform the
    future of cancer treatments

    Learn more

You are now leaving Genmab.com to go to our collaborator’s website. If you continue, we encourage you to read the website’s privacy and cookie policy.